Herantis Pharma's Manager's Transactions
Herantis Pharma Plc
Company release 30 May 2018 at 9:30 am
Herantis Pharma Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Antti Vuolanto
Position: Other senior manager
Issuer: Herantis Pharma Oyj
LEI: 743700W4CQVYAT3WKK38
Notification type: INITIAL NOTIFICATION
Reference number: 743700W4CQVYAT3WKK38_20180530090744_4
____________________________________________
Transaction date: 2018-05-29
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 400 Unit price: 6.1 EUR
Aggregated transactions
(1): Volume: 400 Volume weighted average price: 6.1 EUR
____________________________________________
Transaction date: 2018-05-17
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 400 Unit price: 6.2 EUR
Aggregated transactions
(1): Volume: 400 Volume weighted average price: 6.2 EUR
____________________________________________
Transaction date: 2018-04-09
Venue: FIRST NORTH FINLAND (FNFI)
Instrument type: SHARE
ISIN: FI4000087861
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 300 Unit price: 5.9 EUR
Aggregated transactions
(1): Volume: 300 Volume weighted average price: 5.9 EUR
____________________________________________
Further information:
Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225
Distribution:
Nasdaq Helsinki
Main media
www.herantis.com